We’ve completed our acquisition of Eucalyptus and now Hims & Hers is advancing its position as the world's largest consumer health platform, with a leading presence across U.S., U.K., Australian, and Canadian markets, and a growing presence in France, Germany, Ireland, Japan, and Spain.
Today is about more than a bigger map. It's also about a bigger idea coming into focus.
Healthcare has historically been built around reacting to illness – a one-off doctor’s visit that can take weeks to schedule, a prescription for medication without upfront pricing, and little to no follow-up care afterwards. Piecing these moments together to create a complete picture of health often falls to you as the individual. It’s clear that this system isn’t working for most people.
That’s why we’re so motivated to reimagine health globally by creating a platform that learns over time, proactively discovers early signs of conditions, and adapts with customers as their preferences and goals change. Our global footprint gives us the chance to impact hundreds of millions of lives. Our closed-loop data ecosystem, powered by AI, is what makes that depth of personalization possible at scale. Our local clinical depth is what makes it trustworthy. Together, they create a way of building health that, until now, hasn't existed.
The growing power of our platform doesn't just benefit our customers. It makes us a more powerful partner for the industry. As biotech innovators, diagnostic companies, and leading drugmakers look for a path to reach more people with the next generation of treatment and services, they need more than a distribution channel. They're asking for a partner that can build and sustain long-term relationships with the customers they serve, which can't be done with a single medication or device alone. That's what Hims & Hers offers, now in more places, with more depth than anyone else.
Tim Doyle and the Eucalyptus team have built something rare: a digital health business that works across five very different markets without flattening the differences between them. Today, that team officially joins Hims & Hers, and the platform they’ve built becomes part of what we offer to our customers around the world.
This isn't the end of the work. It's the beginning of what comes next. The same principles that have guided us in the US will guide us from here, putting the customer at the center of every decision, partnering with regional experts who know their markets best, and raising the bar on what healthcare looks like globally.
The years ahead will be measured by what we do for the people who trust us with their everyday health.
Cautionary Note Regarding Forward-Looking Statements
Certain statements contained herein are forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act. These forward-looking statements can be identified by the use of forward-looking terminology, including the words "believes," "estimates," "anticipates," "expects," "intends," "plans," "assume," "may," "will," "likely," "potential," "projects," "predicts," "continue," "goal," "strategy," "future," "forecast," "target," "outlook," "opportunity," "project," "confidence," "foundation," "groundwork," or "should," or, in each case, their negative or other variations or comparable terminology. There can be no assurance that actual results will not materially differ from expectations. Such statements include, but are not limited to, statements regarding the integration of the Eucalyptus business, the international expansion plans of Hims & Hers Health, Inc. (the “Company”), the anticipated impact of the acquisition on the Company's platform capabilities, customer reach, and global network effects, and the Company's long-term financial targets. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, the forward-looking statements contained herein are based on the current expectations, assumptions and beliefs of the Company. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond the Company's control) and other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to: (i) risks related to the integration of the Eucalyptus business, including the ability to successfully combine operations, retain key personnel, and realize the anticipated strategic and financial benefits of the acquisition; (ii) risks related to the Company's international expansion, including challenges in managing operations across multiple jurisdictions and the ability to launch and scale in new markets; (iii) regulatory, compliance, and legal risks in the jurisdictions where the Company operates or plans to operate, including evolving healthcare, consumer protection, and data privacy regulatory frameworks; (iv) risks related to customer adoption and retention across new and existing markets; (v) the Company's ability to achieve its long-term financial targets, which depend on a number of factors including continued growth of the Company's subscriber base, successful integration and expansion of international operations, and broader macroeconomic conditions; and (vi) risks related to the Company's liquidity and capital allocation, including unanticipated demands on cash resources or changes in operating performance, as well as those factors described in the Risk Factors and other sections of the Company's most recently filed Quarterly Report on Form 10-Q, the Company's most recently filed Annual Report on Form 10-K, and other current and periodic reports the Company files from time to time with the Securities and Exchange Commission.
Should one or more of these risks or uncertainties materialize, or should any of the Company's assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. The Company undertakes no obligation (and expressly disclaims any obligation) to update or revise any forward-looking statements, or to update the reasons actual results could differ materially from those anticipated in the forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.
